Warning-style labels are 'overly simplistic' & could mislead or alarm consumers, say industry voices. Consumer groups say industry views dominated talks, and a basic health measure meant to inform the public is being avoided.
New research published in The Journal of Clinical Investigation argues that Alzheimer’s may begin much earlier than previously thought, often between the ages of 45 and 65.
Guidelines by American College of Cardiology, American Heart Association & other organisations endorse early detection and treatment of dyslipidemia—unhealthy levels of fats in blood.
States have consistently underspent funds under District Mental Health Programme, which involves OPD, community outreach, awareness & training of healthcare workers in districts.
Kerala researchers study 386 products, covering Ayurveda, Homoeopathy, Siddha, Unani, other traditional remedies. Findings raise concerns about regulatory oversight of Ayush meds.
Tirzepatide is the active ingredient in Lilly’s popular anti-obesity & diabetes drugs, Mounjaro & Zepbound. Experts say the matter has little relevance for India at present.
In critical care and palliative medicine, doctors say, treatment goals may shift from prolonging life to reducing suffering when recovery is no longer possible.
Experts say ‘surge in cancer cases remains relatively modest on a per capita basis, but actual burden may be higher due to persistent underreporting in rural, underserved regions’.
Dr Sheth also spoke about staffing gaps at NMC, action taken against medical colleges for non-compliance, MBBS fee regulation, and the rollout of the National Exit Test (NExT).
China and India are home to 1.2 billion young people. They’re the pioneers in advancing the rejuvenation of the Chinese nation and realising the vision of ‘Viksit Bharat 2047’.
The countries signed a memorandum for co-development of UNICORN masts in November 2024. India has been second Asian nation to have such an agreement with Tokyo, after Philippines.
COMMENTS